Pemetrexed disodium (Alimta)
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Pemetrexed disodium (Alimta), covering 2014-09-22 to 2017-04-04. Get the full timeline:
Most recent: Clinical Trial Update: Positron Emission Tomography in Predicting Response in Patients Who Are Undergoing Treatment With Pemetrexed Disodium and Cisplatin With or Without Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer [Phase 2]